Elaine Ullian - Net Worth and Insider Trading

Elaine Ullian Net Worth

The estimated net worth of Elaine Ullian is at least $10 Million dollars as of 2024-11-08. Elaine Ullian is the Director of Thermo Fisher Scientific Inc and owns about 10,109 shares of Thermo Fisher Scientific Inc (TMO) stock worth over $6 Million. Elaine Ullian is the Director of Vertex Pharmaceuticals Inc and owns about 5,265 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $3 Million. Elaine Ullian is also the Director of Hologic Inc and owns about 27,302 shares of Hologic Inc (HOLX) stock worth over $2 Million. Details can be seen in Elaine Ullian's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elaine Ullian has not made any transactions after 2017-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Elaine Ullian

To

Elaine Ullian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elaine Ullian owns 3 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , Thermo Fisher Scientific Inc (TMO) , and Hologic Inc (HOLX) .

Click here to see the complete history of Elaine Ullian’s form 4 insider trades.

Insider Ownership Summary of Elaine Ullian

Ticker Comapny Transaction Date Type of Owner
VRTX Vertex Pharmaceuticals Inc 2015-12-01 director
TMO Thermo Fisher Scientific Inc 2013-05-07 director
HOLX Hologic Inc 2017-11-13 director

Elaine Ullian Latest Holdings Summary

Elaine Ullian currently owns a total of 3 stocks. Among these stocks, Elaine Ullian owns 10,109 shares of Thermo Fisher Scientific Inc (TMO) as of May 7, 2013, with a value of $6 Million and a weighting of 53.88%. Elaine Ullian owns 5,265 shares of Vertex Pharmaceuticals Inc (VRTX) as of December 1, 2015, with a value of $3 Million and a weighting of 25.36%. Elaine Ullian also owns 27,302 shares of Hologic Inc (HOLX) as of November 13, 2017, with a value of $2 Million and a weighting of 20.76%.

Latest Holdings of Elaine Ullian

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TMO Thermo Fisher Scientific Inc 2013-05-07 10,109 555.89 5,619,492
VRTX Vertex Pharmaceuticals Inc 2015-12-01 5,265 502.45 2,645,399
HOLX Hologic Inc 2017-11-13 27,302 79.29 2,164,776

Holding Weightings of Elaine Ullian


Elaine Ullian Form 4 Trading Tracker

According to the SEC Form 4 filings, Elaine Ullian has made a total of 0 transactions in Thermo Fisher Scientific Inc (TMO) over the past 5 years. The most-recent trade in Thermo Fisher Scientific Inc is the sale of 8,000 shares on May 7, 2013, which brought Elaine Ullian around $661,840.

According to the SEC Form 4 filings, Elaine Ullian has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 22,500 shares on December 1, 2015, which brought Elaine Ullian around $3 Million.

According to the SEC Form 4 filings, Elaine Ullian has made a total of 0 transactions in Hologic Inc (HOLX) over the past 5 years. The most-recent trade in Hologic Inc is the sale of 9,282 shares on November 13, 2017, which brought Elaine Ullian around $375,921.

Insider Trading History of Elaine Ullian

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Elaine Ullian Trading Performance

GuruFocus tracks the stock performance after each of Elaine Ullian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Elaine Ullian is 31.44%. GuruFocus also compares Elaine Ullian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Elaine Ullian within 3 months outperforms 6 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Elaine Ullian's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Elaine Ullian

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
6 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.81 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.08 LIMIT LIMIT LIMIT LIMIT LIMIT

Elaine Ullian Ownership Network

Ownership Network List of Elaine Ullian

No Data

Ownership Network Relation of Elaine Ullian

Insider Network Chart

Elaine Ullian Owned Company Details

What does Vertex Pharmaceuticals Inc do?

Who are the key executives at Vertex Pharmaceuticals Inc?

Elaine Ullian is the director of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and Chief Legal Officer Jonathan Biller , EVP and CMO Carmen Bozic , and director & CEO & President Reshma Kewalramani .

Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary

Over the past 18 months, Elaine Ullian made no insider transaction in Vertex Pharmaceuticals Inc (VRTX). Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 16,533 shares made by Ourania Tatsis , and a net sale of 77,232 shares made by Reshma Kewalramani .

In summary, during the past 3 months, insiders sold 5,429 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 5,429 shares. During the past 18 months, 340,041 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 340,041 shares.

Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vertex Pharmaceuticals Inc Insider Transactions

No Available Data

Elaine Ullian Mailing Address

Above is the net worth, insider trading, and ownership report for Elaine Ullian. You might contact Elaine Ullian via mailing address: C/o Hologic, Inc., Bedford Ma 01730.